Dr Dia Kamel

Visiting Associate Professor of Pathology; Pathology Theme Lead, ARU School of Medicine

Faculty:Faculty of Health, Education, Medicine and Social Care

School:Medicine

Location: Chelmsford

Areas of Expertise: Anatomy and physiology

Dr Kamel MB BS, PhD, FRCPath is Visiting Associate Professor of Pathology and Pathology Theme Lead at ARU's School of Medicine. He also works as a Consultant in Histopathology at the Mid and South Essex University Hospitals Group's Department of Pathology, based in Broomfield Hospital. He is additionally affiliated to the John Fulcher Neuro-Oncology Laboratory in Imperial College London's Department of Brain Sciences.

Background

Dr Kamel graduated in 1990 (MBBS) from Ain Shams University, Cairo, Egypt. As one of top graduate students, he was awarded a scholarship from the University of Oulu, Finland, where he obtained his MD PhD in 1994. In 1997, he moved to London, where he completed his speciality training at London University Hospitals, successfully obtaining FRCPath and CCST in 2002.

Since then, he has worked as a Consultant in Pathology in the UK, including his current post at Mid and South Essex University Hospitals Group, which he took up in 2007. He became the Pathology Curriculum Lead at ARU's School of Medicine in 2018, and was awarded the post of Visiting Associate Professor of Pathology in 2021.

Dr Kamel has vast experience in anatomical pathology and postmortem examination. He also has a strong academic interest, having been involved in several novel research projects in collaboration with Imperial College London and ARU. His research interests are skin pathology, lympho-reticular pathology, and renal and urogenital pathology.

Spoken Languages

Dr Kamel is fluent in: 

  • English
  • Finnish
  • Arabic

Dr Kamel can communicate in: 

  • French
  • Spanish

Research interests

  1. Genetic alterations/molecular biomarkers in mucosal and skin melanoma with their prognostic significance including mucosal melanoma
  2. Novel Plasma Device with its application human skin
  3. Skin burns treated by INTEGRA Dermal Regeneration; Skin Burns treated with Integra Dermal Regeneration
  4. Skin tumours and correlation to tumour clinical behaviour
  5. Implant associated malignancies; BIA-ALCL and In Vitro Analysis of various types of Implants on Breast Tissue
  6. Procalcitonin as an infection biomarker

Teaching

  • Pathology Theme Lead
  • MMI assessor and examiner for OSCE

Qualifications

2008: FRCPath, RCPath, UK

2002: MRCPath, RCPath, UK

1994: MD PhD Pathology, University of Oulu, Oulu, Finland

2002: CCST (Certificate of Completion Specialty Training, UK and EU)

1990: MBBS, Faculty of Medicine, Ain Shams

Memberships, editorial boards

Editorial roles

2015- 2021: Invited as expert referee and reviewer for manuscripts submitted for publication to Journal of Medical Case Reports.

Memberships

  • The Royal College of Pathologists
  • British Medical Association
  • Pathological Society of Great Britain and Ireland
  • The Association of Clinical Pathologists
  • Finnish Medical Syndicate
  • British Lymphoma Pathology Group
  • British Dermatology Society
  • Egyptian Society of Dermatopathology (founder)
  • International Academy of Pathologists - British Division
  • European Organization on Research and Treatment of Cancer (EORTC)

Research grants, consultancy, knowledge exchange

Research projects

Co-investigator: Detecting infection in native and prosthetic joints using Procalcitonin in a novel way (The research project has attracted internal funding with the possibility of commercial test coming out of it).

Co-investigator: Degenerated intervertebral discs express Procalcitonin a marker of infection (collaboration between Ipswich Hospital, Broomfield Hospital and Plymouth University).

Principal investigator: Identifying molecular markers in Mucosal melanoma (Collaboration between the Imperial college and Broomfield Hospital.

Awards and distinctions

Clinical Excellence Awards Scheme, for active contribution and achievement as UK NHS Consultant: Level 4 (2017)

Clinical Excellence Awards Scheme, for active contribution and achievement as UK NHS Consultant: Level 3 (2014)

Clinical Excellence Awards Scheme, for active contribution and achievement as UK NHS Consultant: Level 2 (2011)

Selected recent publications

Kamel, D., Sood, M., Sadeeki, A., 2021. Squamous cell carcinoma of nail bed, histological analysis with clinical outcome (under preparation).

Irionside, W., Kamel, D., Kadiramanathan, S., 2021. Concomitant triple tumours in subtotal Gastrectomy specimen, case report (under preparation).

Hegab, B., Kamel, D., 2021. Haemophagocytic Syndrome. A pre-existing complication or a subsequent development after Liver Transplantation: A Case Report (submitted).

Kamel, D., Kuopio, T., Rinne, A., Collan, Y., 2021. Prognostic importance of cathepsin S in breast cancer. J Pathol (submitted).

Kamel, D., Järvinen, M., Kuopio, T., 2021. Overexpression of cathepsin B but not cathepsin S in inflammatory Bowel Diseases (under preparation).

Petkar, M., Kamel, D., Dziewulski, P., 2021. Bcl2 and p63 as prognostic markers in Skin Merkel cell carcinomas (under preparation).

Abdellatif, E., Kamel, D., 2020. Breast implant associated anaplastic large cell lymphoma. Pathology Outlines.

Abdellatif, E., Kamel, D., 2019. Neurofibroma-general. Pathology Outlines.

Abdellatif, E., Kamel, D., 2018. Schwannoma. Pathology Outlines.

Kamel, D., Frame, J. (Jnr), Frame, J. D., Harle, T., 2017. Histological Findings from Controlled Application of a Thermal Plasma to Human Skin. Clinics in Surgery, 1, 1176.

Heptinstall, L., Carroll, C., Siddiqi, J., Kamel, D., Petkar, M., 2017. Sclerosing Mucoepidermoid carcinoma of the submandibular gland, presenting as chronic sialadenitis- A case report. Head Neck Patholdoi: 10.1007/s12105-017-0821-2

Delikonstantinou, I., Philp, B., Kamel, D., Barnes, D., Dziewulski, P., 2016. A major burn injury in liver transplant patient. Annals of Burns and Fire Disasters, XXIX(3).

Frame, J., Smith, S., Kamel, D., 2016. A Further case report from the United Kingdom of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and a Reason to avoid the subpectoral plane. Journal of Surgery, 4(5), pp. 89-94.

Shebab, J., Petkar, M., Kamel, D., Frew, Q., Dziewulski, P., 2016. A clinicopathological review of aural squamous cell carcinoma(SCC) and the utility of an Invasive Pattern Grading Score(IPGS) to determine prognosis.

Rupani, A., MBBS, MD, MSc, Frame, J. D., FRCS (Plast), Kamel, D., MD, PhD, FRCPath, 2015. Lymphomas Associated with Breast Implants: A Review of the Literature. Aesthet Surg J, 35(5), pp. 533-544 (selected as editor’s choice 2015, with video recording of last author Dr Dia Kamel). doi: 10.1093/asj/sjv016

Frame, J., Kamel, D., Olivan, M., Cintra, H., 2015. The in Vivo Pericapsular Tissue Response to Modern Polyurethane Breast Implants. Aesthetic Plast Surg, 39(5), pp. 713-723.

Siriwardana, H. P., Harvey, M. H., Kadiramanathan, S. S., Tang, B., Kamel, D., Radzioch, R., 2012. Endoscopic mucosal resection of a solitary metastatic tumour in the stomach: a case report. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, 22(3), e132-4.

Siriwardana, H. P., Tear, L., Kamel, D., Inwang, E. R., 2011. Toxoplasmosis presenting as a swelling in the axillary tail of the breast and a palpable axillary lymph node mimicking malignancy: a case report. Journal of Medical Case reports (electronic resources), 5, 348.

Moimen, N. S., Yarrow, J., Kamel, D., Kearns, D., Mendonca, D., 2010. Topical negative pressure therapy: does it accelerate neovascularisation within the dermal regeneration template, Integra? A prospective histological in vivo study. Burns, 36(6), pp. 764-8, 0305-4179;1879-1409.

Basnayake, K., Cheung, C. K., Sheaff, M., Fuggle, W., Kamel, D., Nakoins, S., Hutchison, C., Cook, M., Stoves, J., Bradwell, A. R., Cockwell, P., 2010. Differential diagnosis of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J Clin Pathol, 63(10), pp. 884-7, 0021-9746; 1472-4146.

Elbahaie, A. M., Kamel, D. E., Lowrence, J., Davidson, N. G., 2009. Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature. World Journal of Surgical Oncology, 7(84).

Basnayake, K., Hutchison, C., Kamel, D., Sheaff, M., Ashman, N., Cook, M., Oakervee, H., Bradwell, A., Cockwell, P., 2008. Resolution of cast nephropathy following free light chain removal by hemodialysis in a patient with multiple myeloma: a case report. Journal of Medical Case reports (electronic resources), 2, 380.

Nolan, S. L., Kalia, N., Nash, G. B., Kamel, D., Heeringa, P., Savage, C. O., 2008. Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo. J Am Soc Nephrol, 19(5), pp. 973-984).

Ravanan, R., Weale, A. R., Lear, P. A., Thronton, M. J., Kamel, D., Tomson, C. R., 2004. Hemoperitoneum in patient with ANCA-associated polyangiitis syndrome. American Journal of Kidney Disease, 44(5), pp. 908-911)

Salmon, A. H., Kamel, D., Mathieson, P., 2004. Recurrence of IgM Nephropathy in Renal Allograft. Nephrology Dialysis Transplantation, 19(10), pp. 2650-2652.

Adwan, H., Patel, B., Kamel, D., Glazer, G., 2004. A solitary encapsulated pelvic aggressive angiomyxoma. Annals of the Royal College of Surgeons of England, 86(6) (W1-3).

El-Rifa, W., Kamel, D., Larramendy, M. L., Shoman, S., Gad, Y., Baithun, S., El-Awady, M., Eissa, S., Khalid, H., Soloneski, S., Sheaff, M., Knuutila, S., 2000. DNA copy number changes in schistosoma-associated and non-schistosoma-associated bladder cancer. Am J Pathol, 156(3), pp. 871-878.

Castren, J. P., Kamel, D. E., Nurmi, M. J., Collan, Y. U., 2000. Cathepsin H expression distinguishes oncocytomas from renal Cell carcinomas. Anticancer Research,, 20(1B), pp. 537-540.

Kamel, D., Kuopio, T., Rinne, A., Collan, Y., 1999. Prognostic value of cathepsin D in breast cancer compared with nuclear morphometric index. Cancer Mol Biol, 6, pp. 401-404.

Pernu, H., Järvinen, M., Kamel, D., Räsänen, O., 1999. Immunohistochemical localization of cystatin A (ACPI) in Oral Squamous cell carcinomas. Cancer Mol Biol, 7, pp. 201-204.

Kamel, D., Mackey, Z. B., Sjoblom, T., Walter, C. A., McCarrey, J. R., Uitto, L., Palosaari, H., Lähdetie, J., Tomkinson, A. E., Syväoja, J. E., 1997. Role of deoxyribonucleic acid polymerase epsilon in spermatogenesis in mice. Biology of Reproduction, 57(6), pp. 1367-1374, 0006-3363;0006-3363.

Soini, Y., Nuorva, K., Kamel, D., Pöllänen, R., Vähäkangas, K., Lehto, V. P, Pääkkö, P., 1996. Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma. Thorax, 51(9), pp. 887-893.

Kamel, D., Pääkkö, P., Pöllänen, R., Vähäkangas, K., Lehto, V .P, Soini, Y., 1995. Human papillomavirus DNA and abnormal p53 protein expression in carcinoma of the urinary bladder. AMPS, 103, pp. 331-338.

Nuorva, K., Soini, Y., Kamel, D., Pöllänen, R., Bloigu, R., Vähäkangas, K., Pääkkö, P., 1995. p53 protein accumulation and presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlates with poor prognosis. Int J Cancer, 64, pp. 424-429.

Kamel, D., Hopsu-Havu, V., Khalifa, A., Mangoud, A., Järvinen, M., Rinne, A., 1995. Immunohistochemical localization of cystatin A in schistosomal urinary bladder carcinoma. Cancer Mol Biol, 2, pp. 507-513

Soini, Y., Mannermaa, A., Winqvist, R., Kamel, D., Poikonen, K., Kiviniemi, H., Pääkkö, P., 1994. Application of fine needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma. J Histochem Cytochem, 42, pp. 795-803.

Nuorva, K., Mäkitaro, R., Huhti, E., Kamel, D., Vähäkangas, K., Bloigu, R., Soini, Y., Pääkkö, P., 1994. p53 protein accumulation in lung carcinoma of patients exposed to asbestos and tobacco smoke. Am J Respir Crit Care Med, 150, pp. 528-533.

Kamel, D., Soini, Y., Nuorva, K., Khalifa, A., Mangoud, A., Vähäkangas, K., Pääkkö, P., 1994. p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions. Virchows Arch [A], 424, pp. 349-355.

Soini, Y., Niemelä, A., Kamel, D., Herva, R., Bloigu, R., Pääkkö, P., Vähäkangas, K., 1994. p53 immunohistochemical positivity as a prognostic marker in intracranial tumors. APMIS, 102, pp. 786-792.

Soini, Y., Kamel, D., Pääkkö, P., Lehto, V. P., Oikarinen, A., Vähäkangas, K., 1994. Aberrant accumulation of p53 associates with ki67 and mitotic count in benign skin lesions. Br J Dermatol, 131, pp. 514-520

Kamel, D., Pääkkö, P., Turpeenniemi-Hujanen, T., Vähäkangas, K., Soini, Y., 1994. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma. Histopathol, 25, pp. 339-347

Kamel D., 1994. Expression of p53 protein in urological tumors: correlation with the presence of human papillomavirus DNA, Proliferating cell nuclear antigen (PCNA) and prognosis. (Doctoral thesis) ACTA Universitatis Ouluensis Medica D 312.

Nuorva, K., Soini, Y., Kamel, D., Autio-Harmainen, H., Risteli, L., Risteli, J., Vähäkangas, K., Pääkkö, P., 1993. Concurrent p53 expression in bronchial dysplasia and squamous cell lung carcinomas. Am J Pathol, 142, pp. 725-732.

Kamel, D., Pääkkö, P., Nuorva, K., Vähäkangas, K., Soini, Y., 1993. p53 and  c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder. J Pathol, 170, pp. 67-72.

Soini, Y., Kamel, D., Apaja-Sarkkinen, M., Virtanen, I., Lehto, V. P., 1993. Tenascin immunoreactivity in normal and pathological bone marrow. J Clin Pathol, 46, pp. 218-221.

Soini, Y., Pääkkö, P., Nuorva, K., Kamel, D., Linnala, A., Viranen, I., Lehto, V. P., 1993. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol, 100, pp. 145-150.

Soini, Y., Turpeenniemi-Hujanen, T., Kamel, D., Nuorva, K., Vähäkangas, K., Autio-Harmainen, H., Vähäkangas, K., Pääkkö, P., 1993. p53 Immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer, 68, pp. 1029-1035.

Pääkkö, P., Nuorva, K., Kamel, D., Soini, Y., 1992. Evidence by In Situ Hybridization that c-erbB-2 Proto-oncogene Expression Is a Marker of Malignancy and is Expressed in Lung Adenocarcinomas Am J Respir Cell Mol Biol, 7, pp. 325-334.

Soini, Y., Vähäkangas, K., Nuorva, K., Kamel, D., Lane, D., Pääkkö, P., 1992. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumors. J Pathol, 168, pp. 29-33.

Soini, Y., Pääkkö, P., Nuorva, K., Kamel, D., Lane, D., Vähäkangas, K., 1992. Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch [A], 421, pp. 223-228.

Soini, Y., Kamel, D., Nuorva, K., Lane, D., Vähäkangas, K., Pääkkö, P., 1992. Low p53 protein expression in salivary gland tumors compared with lung carcinomas. Virchows Arch [A], 421, pp. 415-420.

Recent presentations and conferences

Ali, A., Kamel, D., 2019. Sclerosing variant of mucoepidermoid carcinoma: an indication of molecular testing, ECP, 2019.

Irionside, W., Kamel, D., Kadiramanathan, S., 2013. Concomitant triple tumors in subtotal Gastrectomy specimen, case report, ACP Summer meeting, UK, 2013.

Petkar, M., Kamel, D., Dziewulski, P., 2011. Bcl2 and p63 as prognostic markers in Skin Merkel cell carcinomas, British Association of Dermatology meeting, 2011.

Kamel, D., 2005. Update in reporting prostate biopsy, Abstract for the International Union Against Cancer, the Annual Conference, Cancer in developing Countries, Cairo, Egypt, 21-25 March 2005.

Kamel, D., Larramendy, M., Shoman, S., Gad, Y., Baithun, S., Eissa, S., Soloneski, S., Sheaff, M., Knuutila, S., 2000. DNA copy number changes in schistosoma-associated and non-schistosoma-associated bladder cancer.Abstract for Path Soc of GB and Irland winter meeting, London, 18-20 January 2000.

Kamel, D., 1999. DNA damage and repair: clinical applications. Lecture presentation in the International Conference of the Egyptian Laboratory Society, 7-9 April 1999.

El-Refai, W., Kamel, D., Laramandy, M., Shoman, S., Knuutila S. Changes in DNA copy numbers between schistosomal and non-schistomal bladder cancer. Abstract for ESMG, Amsterdam, 1999.

Kamel, D., Järvinen, M., Rinne, A., Feakins, R. M., 1998. Overexpression of cathepsin B but not cathepsin S in inflammatory Bowel Diseases. Abstract for Pathological Society of Great Great Britain and Ireland Winter meeting, London, 7-9 January 1998.

Kamel, D., Kuopio, T., Sheaff, M., Baithun, S., Collan, Y., 1998. Acid cysteine protease inhibitor (cytatin A) Differentiates Oncocytomas from Renal Cell carcinomas. Abstract for Pathological Society of Great Britain & Ireland, Winter meeting, London, UK, January 1998.

Syväöja, J., Kamel, D., 1996. DNA polymerase epsilon is required for late stages of meiotic recombination during spermatogenesis. Abstract for EMBO workshop 96, molecular biology of DNA replication, Switzerland, 8-13 September 1996.

Kamel, D., Kuopio, T., Rinne, A., Collan, Y., 1996. Expression of cathepsin B and S in breast cancer. Abstract for the 11th International Conference on Proteolysis and Protein Turnover, International Committee on Proteolysis, Turku, Finland, September 1996.

Kamel, D., Rinne, R., Saukko, P., Hopu-Havu, V. K., Järvinen, M., Rinne, A., 1996. Cystatin A in normal and diseased liver. Abstract for the 11th International Conference on Proteolysis and Protein Turnover, International Committee on Proteolysis, Turku, Finland, September 1996.

Kamel, D., Saukko, P., Hopsu-Havu, V. K., Järvinen, M., Rinne, A.. Immunolocalization of cathepsin B in normal and diseased liver. Abstract for the First European Symposium, The Protein Society, Conference Center, Davos, Switzerland, 29 May - 1 June 1995.

Kamel, D., Rinne, R., Saukko, P., Hopu-Havu, V. K., Järvinen, M., Rinne, A., 1995. Acid Cysteine proteinase inhibitor (ACPI) in normal and diseased liver. Abstract for the First European Symposium, The Protein Society, Conference Center, Davos, Switzerland, 29 May - 1 June 1995.

Kamel, D., Hopsu-Havu, V., Khalifa, A., Mangoud, A., Järvinen, M., Rinne, A., 1995. Immunohistochemical localization of cystatin A in schistosomal urinary bladder carcinoma. Abstract for the XVIII International Annual Ain Shams Congress, Cairo, Egypt, March 1995.

Pääkkö, P., Nuorva, K., Mäkitaro, R., Huhti, E., Kamel, D., Vähäkangas, K., Soini, Y., 1994. Abnormal p53 protein accumulation is increased in lung carcinomas from patients exposed to asbestos. Abstract for the third annual meeting of the Finnish Cancer Researchers, 5-7 October 1994, Hotel Eden, Oulu, Finland.

Kamel, D., Tuusa, J., Uitto, L., Syväoja, J., 1994. Expression of DNA polymerase epsilon in cultivated mammalian cells and tissues. Abstract for European Research Conferences, Mechanism of DNA Damage and Repair, Giens, France, 22-27 September 1994.

Kamel, D., Pääkkö, P., Turpeenniemi-Hujanen, T., Vähäkangas, K., Soini, Y., 1994. Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma. Abstract for European Research Conferences, The molecular Epidemiology of Cancer, Aghia Pelaphia, Crete, Greece, September 1994.

Pääkkö, P., Nuorva, K., Mäkitaro, R., Huhti, E., Kamel, D., Vähäkangas, K., Soini, Y., 1994. Abnormal p53 protein accumulation is increased in lung carcinomas from patients exposed to asbestos. Abstract for American Lung Association and American Thoracic Society International Conference. 21-25 May 1994, Boston, Massachusetts, USA.

Kamel, D., Soini, Y., Pöllänen, R., Vähäkangas, K., Pääkkö, P., Lehto, V. P. Human papillomavirus DNA and p53 protein expression in bladder carcinoma. Abstract for The Second International Cancer Molecular Biology Symposium, November 1993, Cairo, Egypt.

Rainio, P., Lepojärvi, M., Soini, Y., Kamel, D., Vähäkangas, K., Pääkkö, P., 1993. Bronco-pulmonary carcinoid tumors. A clinico-pathological study of 18 patients. Abstract for the 42nd Annual Meeting of the Scandinavian Association for Thoracic and Cardiovascular Surgery, 12-14 August 1993, Tampere, Finland, p. 127.

Pääkkö, P., Nuorva, K., Soini, Y., Kamel, D., Autio-Harmainen, H., Risteli, L., Risteli, J., Vähäkangas, K., 1993. Concurrent p53 expression in bronchial dysplasia and squamous cell lung carcinomas. Abstract for the International Conference of American Lung Association, American Thoracic Society, 16-19 May 1993, San Francisco, California, USA, p. A776.

Vähäkangas, K., Kamel, D., Pääkkö, P., Lehto, V. P., Soini, Y., 1993. Positive p53 Immunohistochemistry in non-neoplastic skin diseases does not correlate with Ki67, a proliferation marker. Abstract for First Scientific Symposium p53 In Growth Control and Neoplasia, 24-27 March 1993, Zurich, Switzerland, p. 66.

Pääkkö, P., Nuorva, K., Kamel, D., Soini, Y., 1992. Evidence by In Situ Hybridization that c-erbB-2 Proto-oncogene Expression Is a Marker of Malignancy and Is Expressed in Lung Adenocarcinomas. Abstract for The First International Cancer Molecular Biology Symposium, 1-3 December 1992, Cairo, Egypt, pp. 59-60.

Kamel, D., Soini, Y., Nuorva, K., Khalifa, A., Mangoud, A., Vähäkangas, K., Pääkkö, P., 1992. p53 and c-erbB-2 expression in bilharzial urinary bladder carcinomas and bilharzial cystitis with premalignant lesions. Abstract for The First International Cancer Molecular Biology Symposium, 1-3 December 1992, Cairo, Egypt, p. 76.

Soini, Y., Pääkkö, P., Nuorva, K., Kamel, D., Linnala, A., Virtanen, I., Lehto, V. P. Tenascin in benign and malignant lung tumors. Abstract for the Seventh International Conference of The International Society of Differentiation (Cellular Programs for Growth, Differentiation, and Neoplasia), 19-23 July 1992, Helsinki, Finland, p. 40.

Kamel, D., Soini, Y., Pääkkö, P., Nuorva, K., Autio-Harmainen, H., Risteli, J., Risteli, L., Vähäkangas, K., 1992. p53 protein expression in dysplasia of the urinary bladder and in transitional cell carcinomas. Abstract for the Seventh International Conference of The International Society of Differentiation (Cellular Programs for Growth, Differentiation, and Neoplasia), 19-23 July 1992, Helsinki, Finland, p. 96.

Vähäkangas, K., Soini, Y., Nuorva, K., Kamel, D., Lane, D., Pääkkö, P., 1992. Low p53 tumor suppressor gene expression in prostatic, breast and salivary gland carcinomas compared with lung carcinomas. Eighty-Third Annual Meeting of the American Association for Cancer Research, 20-23 May 1992, San Diego, California, USA. Proceeding of the American Association for Cancer Research, 1992; 33: 388.

Kamel, D., Soini, Y., Pääkkö, P., Nuorva, K., Lane, D., Vähäkangas, K., 1002. Low tumor suppressor gene p53 expression in prostate carcinomas as compared with breast and lung carcinomas. Abstract for the XV International Annual Ain Shams Medical Congress. Cairo, Egypt, 21-24 February 1992, pp. 48-49.